ET
Energy Transfer LP Common Units
stockNYSE

| Ticker | Target | Entry | Current | Move | Expires | |:---:|:---:|:---:|:---:|:---:|:---:| | **QQQ** ▼ | $691.03 (below) | $743.04 | $725.59 | -7.0% | Tue 10:39 AM ET |

**BanBet Created** ▼ | Ticker | Target | Entry | Move | Expires | |:---:|:---:|:---:|:---:|:---:| | **AMD** | $545.73 (below) | $551.24 | -1.0% | Thu 4:34 PM ET |

cheap filter you can check right now: tag each trade by entry time. midday breaks (roughly 11:30 to 2 ET) fail a lot more since volume dries up, and I'd bet most of your failed ones sit in that window

My understanding is that your excess liquidity must always be positive, so as far as I can tell, you are already in violation, and a liquidation could happen at any moment. The SMA only applies during 3:50-5:20 p.m. ET (near the close) and it must be positive there. That's not your issue. IBKR will probably liquidate, not issue a margin call. Maybe you can close positions yourself in a way that does less damage.

📉 Semafor reports Meta plans to create nonvoting shares and sell more stock, possibly announced as soon as today (3:19 PM ET). That firms up the earlier speculation that Meta would sell stock to pay for AI spending, which means dilution and more worry about how AI spending gets funded. SPY: pressure on Meta and the Nasdaq into the close, a mild headwind for SPY. Watch for a formal announcement, likely with earnings tonight. FinancialJuice Smaller: Kyiv's mayor says the city is under ballistic missile attack (3:17 PM ET), just after Trump said a Russia-Ukraine settlement is getting closer. FirstSquawk

**BanBet Created** ▲ | Ticker | Target | Entry | Move | Expires | |:---:|:---:|:---:|:---:|:---:| | **NFLX** | $69.03 (above) | $65.74 | +5.0% | Fri 2:49 PM ET |

**Levels** The most recent 15-minute swing high and swing low that had finished forming before the London open. London open is 08:00 London time converted to New York time each day, so it’s normally 03:00 ET and shifts during the weeks when US and UK daylight saving don’t line up. A swing high is a 15-minute candle whose high is strictly above the k candles on each side (swing low is the mirror). k = 2 or 3. Built from overnight and prior-day candles, up to 4 days back. **Trading window** From the London open to 16:00 ET. The first 15-minute candle after the London open can’t count as a breakout or a rejection. New entries until 15:30 ET; anything still open closes at the 15:59 ET bar. One position at a time; each level-and-setup combination trades at most once a day. **Setups** A – break and retest: a 15-minute candle closes beyond the level, then a limit order sits at the level for the retest. A break above the swing high goes long; a break below the swing low goes short. B – third rejection: while the level is unbroken, a 15-minute candle that wicks through it and closes back inside counts as one rejection. After two, the next touch is faded (short at the high, long at the low). A 15-minute close through the level cancels B, but only before entry. Once in a trade, only the stop, the target or the time exit closes it. Closes back through the level don’t, as in the author’s long example. Versions run: A only, B only, A + B. **Stops (5 versions)** SC: 1 tick beyond the breakout candle (A) or beyond the highest or lowest rejection wick (B). A1 / A15 / A2 / A3: 1×, 1.5×, 2× or 3× the average 15-minute range (the 14 candles before the London open), measured from the level. If a stop isn’t at least 1 tick from the entry, there’s no trade. **Targets (3 versions; all skip the trade unless the target is at least 2× the risk away)** TPX: exit at the next level of interest in the trade direction. That list includes every 15-minute swing from the last 4 days, the prior regular-session high and low, the overnight high and low, and round 50-point numbers. T2R: same filter, but exit at exactly 2× the risk. TOPP: rejection trades target the opposite level (a long from the swing low targets the swing high, and vice versa). Breakout trades target the next major level only: prior regular-session high/low, overnight high/low, round 50s. Added in amendment B1 after the 4-day swing list proved too crowded to allow wide stops. **Fills** Conservative (the one judged): The limit entry needs price to trade 1 tick through the level. The stop fills 1 tick worse (or at the open if price gaps through). The target needs a 1-tick trade-through. A bar that touches both stop and target counts as a stop. On the entry bar only the stop is checked. Optimistic (diagnostic only): fills on a touch, and a bar touching both counts as a win. **Grid and pass bar** 2 swing sizes × 5 stops × 3 targets × 3 setup versions = 90 versions, each with both fill modes. To pass: 150+ trades, t ≥ 3, profit factor ≥ 1.15, both 2013–19 and 2020–26 profitable, and 60%+ of years positive. The 10 best versions on 2013–19 also had to hold up on 2020–26. **The versions closest to the author’s (~1 trade a day)** Swing size 2 or 3, stop SC or A1, target TOPP, both setups. They took 205–265 trades a year, won 13–21% of the time, and lost $25–37 per trade, losing in every year from 2016–26. The author reports 38–55% win rates.

📉 The NY Post reports speculation that Meta could issue new stock to fund its AI spending (1:00 PM ET). That's only speculation, and it lands just before Meta reports tonight. It adds to the worries about how AI spending gets paid for, so it's a likely small drag through Meta and the other big tech names. LiveSquawk

**BanBet Created** ▲ | Ticker | Target | Entry | Move | Expires | |:---:|:---:|:---:|:---:|:---:| | **TSLA** | $400.00 (above) | $387.35 | +3.3% | Sat 1:11 PM ET |

*— Report will be subject of New England CEPAC meeting in May 2027; Draft Scoping Document open to public comment until November 10, 2026 —* **BOSTON, October 21, 2026** – The Institute for Clinical and Economic Review ([ICER](https://icer.org/)) announced today that it will assess the comparative clinical effectiveness and value of synthetic psilocybin (COMPASS Pathways) for treatment-resistant depression. The therapy is also referred to as COMP360. The assessment will be publicly discussed during a meeting of the [New England Comparative Effectiveness Public Advisory Council (CEPAC)](https://icer.org/who-we-are/people/independent-appraisal-committees/new-england-cepac/) in May 2027, where the independent evidence review panel will deliberate and vote on evidence presented in ICER’s report. ICER’s website provides [timelines of key posting dates and public comment periods for this assessment](https://icer.org/?post_type=assessment&p=23880). Consistent with ICER’s process for announcing new assessments, we have spent the past five weeks conducting outreach and engaging with targeted stakeholders, including the manufacturer, relevant patient groups and clinical experts. Based on this preliminary cross-stakeholder engagement, today ICER has posted a [Draft Scoping Document](https://icer.org/wp-content/uploads/2026/10/ICER_TRD_Draft-Scope_For-Publication_102126-1.pdf)outlining how we plan to conduct this assessment.    All interested stakeholders are encouraged to submit comments and suggested refinements to the scope to ensure all perspectives are adequately considered. Comments can be submitted by email to [publiccomments@icer.org](mailto:publiccomments@icer.org) and must be received by 5 PM ET on November 10, 2026. Please submit public comments as a Word document in the following format:   ICER’s [Patient Portal](https://icer.org/patients/) and [Manufacturer Engagement Guide](https://icer.org/wp-content/uploads/2025/09/ICER_Mfr_Engagement_Guide_01062026.pdf) provide additional guidance for submitting public comments, including suggestions for what types of information may be most useful. In addition to comments on the scope, ICER also welcomes submissions from stakeholders on examples of low-value care practices within this clinical area. These submissions will inform a report section focused on strategies to reduce waste and preserve resources for high-value, potentially higher-cost treatments. More information is available in the scoping document. Following the public comment period, a revised scoping document will be posted on or about November 18, 2026. **About ICER** The Institute for Clinical and Economic Review ([ICER](https://icer.org/)) is an independent, non-profit research institute that conducts evidence-based reviews of health care interventions, including prescription drugs, other treatments, and diagnostic tests. In collaboration with patients, clinical experts, and other key stakeholders, ICER analyzes the available evidence on the benefits and risks of these interventions to measure their value and suggest fair prices. ICER also regularly reports on the barriers to care for patients and recommends solutions to ensure fair access to prescription drugs. For more information about ICER, please visit [www.icer.org](http://www.icer.org/).

| Ticker | Target | Entry | Current | Move | Expires | |:---:|:---:|:---:|:---:|:---:|:---:| | **AMZN** ▲ | $274.37 (above) | $249.43 | $263.41 | +10.0% | Thu, Nov 5, 7:24 AM ET | | **Record** | 1W - 3L | 25% | - | - | - |

[r/mutualfunds > Wiki](https://www.reddit.com/r/mutualfunds/wiki/index/): [ET Money Blog: Daily or weekly SIPs don’t enhance your returns significantly.](https://www.etmoney.com/learn/mutual-funds/which-is-better-daily-or-weekly-or-monthly-sip/)

Thank you for sharing this experience with us. We strongly encourage you to connect with our Pensions team over the phone, generally available Monday through Friday from 8:30 a.m. to 8:00 p.m. ET, through the following link. Please say "Pensions" when prompted to be routed appropriately. [Contact Us](https://www.fidelity.com/customer-service/contact-us) Please let us know if you have other questions.

**BanBet Created** ▲ | **Record:** 2W - 0L | Ticker | Target | Entry | Move | Expires | |:---:|:---:|:---:|:---:|:---:| | **RDDT** | $180.00 (above) | $158.15 | +13.8% | Wed, Oct 28, 11:21 AM ET |

**BanBet Created** ▼ | Ticker | Target | Entry | Move | Expires | |:---:|:---:|:---:|:---:|:---:| | **MU** | $850.00 (below) | $904.71 | -6.0% | Mon 10:06 AM ET |

Hey there, hopping in. To be specific, the CBOE extended-hours trading session runs from 8:15 p.m. to 9:25 a.m. ET. We only support extended-hours trading from 7:30 a.m. to 9:25 a.m. ET for stock and ETF options on eligible trading days.

There's no sign of a real change. The only recent GameStop filing is the Oct 19 reminder 8-K, and nothing new has been filed since. An actual change to the warrant terms, like extending the deadline or cutting the strike, would need a new 8-K or press release, and there isn't one. That alert comes from your broker's corporate-actions system. The 19:35 timestamp is probably UTC, which would make it 3:35pm ET yesterday. The notice doesn't say what was amended. My best guess is that the broker loaded the details from the Oct 19 notice into its own system. Those details are the $32 cash exercise price, the 5pm ET Oct 30 expiry, and the Nov 2 deadline for guaranteed delivery. To be sure, ask your broker what changed. The line saying previous elections stand is standard text.

Hello! We appreciate you bringing your requests to our attention here. We offer the ability for investors to see how markets and investments are moving during the Extended-Hours sessions, from 7:00 a.m. to 9:28 a.m. ET for pre-market and 4:00 p.m. to 8:00 p.m. ET for after-market. I understand it'd be helpful to see the changes occurring overnight. I'll share your request with the appropriate teams so that they're aware as they plan updates to our platforms. In terms of historical performance, are you trying to find this information on the mobile app or on Fidelity.com? I ask because we have the Performance tab on Fidelity.com, which provides historical returns for accounts. If you've reviewed that section and you're still missing some information, we'd love to know what that is so that we can share that feedback as well. We'll be looking for your response to hear more, and I hope you have a great week.

I have this sent to myself about 15 minutes before market opening: \`\`\` PREMARKET Tue 10/20 09:13 ET | PDH/PDL = 2026-10-19 RTH ABOVE PDH (0) none BELOW PDL (18) TKR PRICE CHG PDL BEYOND DRAM 46.91 -2.94% 48.07 -2.41% HOOD 94.76 -1.82% 96.47 -1.77% SMCI 31.44 -2.06% 31.92 -1.50% MARA 7.20 -2.44% 7.30 -1.37% MU 890.43 -1.60% 900.57 -1.13% DELL 443.59 -2.60% 448.55 -1.11% INTC 90.88 -1.25% 91.88 -1.09% MSTR 134.39 -1.20% 135.80 -1.04% AMD 531.89 -1.14% 535.67 -0.71% WYFI 11.32 -3.73% 11.40 -0.69% MRVL 233.50 -1.51% 234.82 -0.56% GLD 377.17 -0.66% 379.12 -0.51% CRWV 58.96 -3.53% 59.25 -0.49% COIN 166.75 -1.01% 167.49 -0.44% AAPL 339.30 -1.06% 340.12 -0.24% QQQ 715.72 -0.37% 716.57 -0.12% SPY 765.75 -0.10% 765.82 -0.01% SPCX 146.83 -0.77% 146.83 -0.00% \`\`\`

https://preview.redd.it/eks990bnzswh1.png?width=3420&format=png&auto=webp&s=83d6ba07e4c0efa77aefa1de962c223835d9dd17 Gold is sitting near the bottom of its recent range. The drivers: **Yields (bearish):** the US 10-year is **5.15%** and the real yield is **2.80%**, both from Monday's close. That makes gold costly to hold. Hot UK CPI is adding to the global yield pressure. **Oil and rate bets (bearish):** WSJ reported that gold fell as crude rose, which feeds inflation and Fed hike fears. **Ukraine talks (bearish):** Witkoff is in Russia to meet Putin, and peace hopes cut safe-haven demand. **Hormuz and Russia-NATO (bullish):** Bloomberg and WSJ report Hormuz shipping attacks, and the Russia-NATO headlines also support gold. An escalation could flip it quickly. **Levels (blue on the chart)** * Resistance zone: **4,131.67-4,156.78**, from the overnight high to the prior day high. * A move back above **4,156.78** would cancel the bearish lean. Above that, the 5-day high is **4,202.28**. * Support zone: **4,105.88-4,111.98**, the overnight low and prior day low. * Below that, the 5-day low is **4,076.88**. The desk's brief names a similar floor near 4,082. **Scenarios** * Bearish: gold fails at the resistance zone, then breaks **4,106** and heads for **4,077**. * Bullish: an escalation in Hormuz or Russia-NATO, or a sustained close above **4,157**. **Next catalyst:** the only scheduled US event is Unemployment Claims on Thursday at 8:30 AM ET (forecast 200K, previous 199K). It's medium impact, so headlines are the bigger risk. NB: This is a lean, not a prediction. Gold only turns bearish if it rejects at resistance and breaks support.

u/FidelityEmilyP I am a little confused still - just to be explicit - has Fidelity started supporting the new extended hours options trading for CBOE supported securities? IIRC, you are implying above that the answer to my question is "yes but only during Fidelity's own extended hours of 730-925 ET" - is that correct?

**BanBet Created** ▼ | **Record:** 0W - 1L | Ticker | Target | Entry | Move | Expires | |:---:|:---:|:---:|:---:|:---:| | **SPY** | $761.36 (below) | $769.05 | -1.0% | Thu 4:10 AM ET |

**BanBet Created** ▼ | **Record:** 16W - 6L | Ticker | Target | Entry | Move | Expires | |:---:|:---:|:---:|:---:|:---:| | **TSLA** | $355.52 (below) | $374.23 | -5.0% | Fri 2:51 AM ET |

| Ticker | Target | Entry | Current | Move | Expires | |:---:|:---:|:---:|:---:|:---:|:---:| | **NVDA** ▼ | $132.20 (below) | $220.33 | $220.75 | -40.0% | Fri, Nov 13, 1:43 PM ET | | **Record** | 10W - 6L | 63% | - | - | - |

Yeah, I'm currently holding most of these (or was recently). My favorite is probably CAIE for the autocallables. * CHPY 39.58% * BCAT 22.40% * DX 19.36% * AGNC 17.02% * IWMI 14.79% * TYG 14.55% * CAIE 14.32% * EFC 13.50% * EMD 12.25% * THW 11.73% * AOD 11.47% * CSWC 10.93% * TDG 8.28% * CAAP 7.22% * UTG 6.96% * ET 6.64% * TIMB 6.09% * O 6.02% * IDVO 5.99%